Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs)

NCT01543971 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Miscellaneous Peripheral Blood Cell Abnormalities

Interventions

DRUG: TXA127
DRUG: Neupogen (filgrastim)

Sponsor

Tarix Pharmaceuticals